PharmaTalkRadio

About This Episode: 

Current efforts to source and disseminate patient insights in clinical trial planning are expensive and time-consuming. 

In this episode, Fabio Gratton, CEO and Co-Founder of InVibe, which was recently acquired by THREAD Research, discusses how patient voice listening technology is enhancing and disrupting clinical research by making it easier to collect and use patient responses. The result could be more patient-centric trials informed by the actual patient voice. 

 

Key Takeaways:

How current listening technology can accurately capture and convey patient responses, emotion and perspectiveThe difference from current methods of sourcing patient feedbackNext steps in the journey of making trials more patient-centric

 

About the Speaker: 

Fabio Gratton, Co-Founder and CEO of inVibe, part of THREAD Research, is a digital health entrepreneur. For over two decades he has adapted his early experience as a Hollywood scriptwriter with innate acumen in science and data to redefine how healthcare companies tell patient stories through technology. Of his many Fortune 5000 ventures, inVibe has transformed market research by enabling

brands to supplement their efforts with flexible, scalable, and impactful voice-driven insights.

For more information about innovation in clinical research, click here. For more information about mobile technologies in clinical trials, click here.

Dr Viney joined the CMO Summit 360° in October 2021 to share her incredible journey in drug discovery and development, founding and leading Pandion Therapeutics and joining the advisory boards of multiple biotech companies. 

Learn more about the 10th annual CMO Summit 360° taking place April 4-5, 2022 here.

In this podcast, hear a keynote session from the 2021 Chief Medical Officer Summit 360˚ with Dr Ron Cohen on his journey founding and building Acorda Therapeutics and leading the company as an MD CEO for 26 years. Dr Cohen also shares advice on how CMOs can best collaborate with their CEOs and add value to their companies.

Learn more about the 10th annual Chief Medical Officer Summit taking place April 4-5, 2022 here.

Dr Viney joins the CMO Summit 360° to share her incredible journey in drug discovery and development, founding and leading Pandion Therapeutics and joining the advisory boards of multiple biotech companies.

In this session, hear from Dr Ron Cohen about his journey founding and building Acorda Therapeutics and leading the company as an MD CEO for 26 years. Dr Cohen will also share advice on how CMOs can best collaborate with their CEOs and add value to their companies.

In this podcast, hear a keynote session from the 2021 Chief Medical Officer Summit 360˚ with Dr Ron Cohen on his journey founding and building Acorda Therapeutics and leading the company as an MD CEO for 26 years. Dr Cohen also shares advice on how CMOs can best collaborate with their CEOs and add value to their companies.

Learn more about the 10th annual Chief Medical Officer Summit taking place April 4-5, 2022 here.

Conference Producer, Andrew Goldstein, walks through what you can expect to learn and who you'll hear from at the upcoming Chief Medical Officer Summit 360º taking place April 4-5, 2022 in Boston, MA, including:

Clinical development and operationsRelationships within the C-suite and team buildingThe role of the CMO in biotech financingExternal communicationsProfessional development

For more information, click here.

About the Episode: 

In this podcast, we discuss the topic of clinical sites shifting to using the own technologies in sponsored trials and how it can advance (and maintain the pace of) clinical research. Our guest, Bryan Spielman, Chief Growth Officer at Advarra lays out the current burden being faced by performing sponsor trials. Mr Spielman also talks about the work Advarra has led in bringing together sites, CROs and sponsors to brainstorm new solutions, and the path forward to encourage wider conversation, acceptance and adoption.

 

Key Takeaways:

Identifying current burdens faced by sitesUnderstanding current attitudes towards site-owned technologySteps forward to benefit both sides of clinical research

 

About the Speaker: 

Bryan Spielman, MBA, is Chief Growth Officer at Advarra and is responsible for driving Advarra’s corporate strategy, mergers and acquisitions, strategic partnerships, and corporate marketing. Spielman brings over 25 years of business development and corporate strategy experience from leading technology companies including those with a focus on life sciences.

 

For more information about innovation in clinical research, click here.

About the Episode: 

Daniel Chen, MD, PhD, Immuno-Oncology 360º 2022 Strategic Advisor, Physician Scientist, Cancer Immunotherapy and Board of Directors, Society for Immunotherapy of Cancer (SITC) and co-author of the Cancer Immunity Cycle, discusses five talks he is excited for, and why, at the upcoming Immuno-Oncology360 conference.

The 2022 summit will be held March 16th through the 18th, 2022 at the New York Marriott Brooklyn Bridge. For more information, and the full agenda, visit www.io360summit.com. 

 

5 Top Topics To Watch from Dan Chen: 

ctDNA Guiding Adjuvant ImmunotherapyClinical Data on PSMA BiTeNovel Approaches to Expand the Therapeutic Index of T cell EngagersSynthetic BiologyIO360° Debate: NK-Cars vs T cell- CARs

This 7 minute podcast summarizes what you can expect at the 8th annual Immuno-Oncology 360° conference. IO360˚convenes stakeholders spanning the science and business communities to report on the latest data impacting immuno-oncology to fight a wider range of cancers.

Keynotes include:

Dr Gregg Semenza, Johns Hopkins University School of MedicineDr Rachel Haurwitz, Caribou BiosciencesDr Christine Brown, City of HopeDr Suzanne Topalian, Johns Hopkins UniversityDr Andrew Baum, Citi

Key topic areas include:

Discovery/Preclinical ScienceCell & Gene TherapyTranslational ScienceBispecificsClinical DevelopmentsNeoadjuvant/Adjuvant DataEmerging BiomarkersCytokinesClinical OperationsIO CombinationsImaging AdvancementsBusiness Developments

The conference takes place February 16-18, 2022 at the New York Marriott Brooklyn Bridge, New York City, NY. For more information please visit www.io360summit.com or contact us at [email protected]